Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)
Clinical trial NCT00725283 · COMPLETED
Trial details
- NCT number
- NCT00725283
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2016-06-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.